These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Whitwell JL; Jack CR; Parisi JE; Gunter JL; Weigand SD; Boeve BF; Ahlskog JE; Petersen RC; Dickson DW; Josephs KA Eur J Neurol; 2013 Oct; 20(10):1417-22. PubMed ID: 23746093 [TBL] [Abstract][Full Text] [Related]
25. Characterizing the Clinical Features and Atrophy Patterns of Young AL; Bocchetta M; Russell LL; Convery RS; Peakman G; Todd E; Cash DM; Greaves CV; van Swieten J; Jiskoot L; Seelaar H; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonça A; Tagliavini F; Santana I; Ducharme S; Butler C; Gerhard A; Levin J; Danek A; Otto M; Sorbi S; Williams SCR; Alexander DC; Rohrer JD; Neurology; 2021 Aug; 97(9):e941-e952. PubMed ID: 34158384 [TBL] [Abstract][Full Text] [Related]
26. Neuropathology and emerging biomarkers in corticobasal syndrome. Koga S; Josephs KA; Aiba I; Yoshida M; Dickson DW J Neurol Neurosurg Psychiatry; 2022 Jun; 93(9):919-29. PubMed ID: 35697501 [TBL] [Abstract][Full Text] [Related]
27. Anatomical differences between CBS-corticobasal degeneration and CBS-Alzheimer's disease. Josephs KA; Whitwell JL; Boeve BF; Knopman DS; Petersen RC; Hu WT; Parisi JE; Dickson DW; Jack CR Mov Disord; 2010 Jul; 25(9):1246-52. PubMed ID: 20629131 [TBL] [Abstract][Full Text] [Related]
28. Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations. Brittain C; McCarthy A; Irizarry MC; McDermott D; Biglan K; Höglinger GU; Lorenzl S; Del Ser T; Boxer AL; ; ; ; Parkinsonism Relat Disord; 2019 Mar; 60():138-145. PubMed ID: 30201421 [TBL] [Abstract][Full Text] [Related]
29. Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum. Shen T; Vogel JW; Duda J; Phillips JS; Cook PA; Gee J; Elman L; Quinn C; Amado DA; Baer M; Massimo L; Grossman M; Irwin DJ; McMillan CT Transl Neurodegener; 2023 Dec; 12(1):57. PubMed ID: 38062485 [TBL] [Abstract][Full Text] [Related]
30. In vivo retention of Smith R; Schöll M; Widner H; van Westen D; Svenningsson P; Hägerström D; Ohlsson T; Jögi J; Nilsson C; Hansson O Neurology; 2017 Aug; 89(8):845-853. PubMed ID: 28754841 [TBL] [Abstract][Full Text] [Related]
31. Metabolic and Structural Signatures of Speech and Language Impairment in Corticobasal Syndrome: A Multimodal PET/MRI Study. Parmera JB; de Almeida IJ; de Oliveira MCB; Silagi ML; de Godoi Carneiro C; Studart-Neto A; Ono CR; Reis Barbosa E; Nitrini R; Buchpiguel CA; Brucki SMD; Coutinho AM Front Neurol; 2021; 12():702052. PubMed ID: 34526958 [No Abstract] [Full Text] [Related]